MedTrace Logo

Pilot Study of Multi-wavelength Laser for Tattoo Removal

NCT03290547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-09-15

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and efficacy of an investigational version of the Cutera enLighten laser that offers muliple wavelengths for tattoo removal.

Conditions

  • Tattoo Removal

Interventions

DEVICE

Cutera enLighten laser

Subjects will receive laser treatments.

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, M.D. · Cutera Research Center

  • Jeffrey Dover, M.D. · Skin Care Physicians

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-08
Primary Completion
2017-11-29
Completion
2017-11-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290547 on ClinicalTrials.gov